INTERNATIONAL PATENT: ACRIVON THERAPEUTICS, INC. FILES APPLICATION FOR "METHODS AND SYSTEMS FOR TREATING DISEASE USING AN ATR/CHEK1 SIGNALING PATHWAY INHIBITOR"

GENEVA, July 21 -- ACRIVON THERAPEUTICS, INC. (480 Arsenal WaySuite 100Watertown, Massachusetts 02472) filed a patent application (PCT/US2025/011193) for "METHODS AND SYSTEMS FOR TREATING DISEASE USING AN ATR/CHEK1 SIGNALING PATHWAY INHIBITOR" on Jan 10, 2025. With publication no. WO/2025/151786, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BLUME-JENSEN, Peter (c/o Acrivon Therapeutics, Inc.480 Arsenal WaySuite 100Watertown, Massachusetts 02472), DUNYAK, James (c/o Acrivon Therapeutics, Inc.480 Arsenal WaySuite 100Wate...